AstraZeneca demolishing unused site; Taiwan nails companies for using industrial ingredients

> The Taiwan FDA has suspended two companies for using industrial-grade ingredients in stomach medicines. Story

> The European Medicines Agency plans to work with national regulators to share information about inspections and supply issues to improve efficiencies and reduce the risk of counterfeit drugs making their way into the legit supply chain. Report 

> Blisterpack producer Klöckner Pentaplast Group has opened a facility in the University of Virginia Research Park in Charlottesville, VA. Report

> AstraZeneca ($AZN) has started demolishing a 450,000-square-foot former laboratory space at its North American headquarters campus in Fairfax, VA. Story

> Theravectys has gotten approval from French regulators for its new manufacturing facility where it will produce lentiviral vectors for clinical development and do cell work for chimeric antigen receptors (CARs) and T-cell receptor (TCR)-based cell therapies. Report

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.